Carpl.ai has secured the CE mark for its enterprise imaging AI platform.
The universal AI viewer integrates with any PACS system, and allows radiologists to accept, reject or modify AI outputs and streamline tasks such as exam prioritization, the company noted.
Carpl.ai received clearance for the platform from the U.S. Food and Drug Administration (FDA) in May of this year. It is currently being used by Massachusetts General Hospital (MGH) in Boston, MA; University Hospitals in Cleveland, OH; and the Singapore Government Healthcare System, according to the firm. Carpl.ai plans showcase the platform at the upcoming RSNA meeting, it said.
